Dagmar Homerová
- Endocrinology top 5%
- Pharmacology top 5%
- Microbial Natural Products and Biosynthesis 29
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 7
- Biotechnology top 5%
- Genetics top 5%
- Bacterial Genetics and Biotechnology 24
-
- Plant-Microbe Interactions and Immunity 14
-
- Genomics and Phylogenetic Studies 14
- RNA and protein synthesis mechanisms 8
- Bacterial biofilms and quorum sensing 7
-
- Salmonella and Campylobacter epidemiology 11
- Co-authors
- Ján KormanecBronislava ŘežuchováMark RobertsRenáta NovákováBeatrica Ševčı́kováMarkus BischoffLubomira FeckovaGary Rowley
- Journals
- Nucleic Acids Research (1 paper)Journal of Biological Chemistry (1 paper)Analytical Biochemistry (1 paper)
- Partner nations
- SlovakiaUnited KingdomGermany
In The Last Decade
Dagmar Homerová
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 78
- Endocrinology 169
- Pharmacology 342
- Infectious Diseases 349
- Biotechnology 133
- Genetics 419
Countries citing papers authored by Dagmar Homerová
This map shows the geographic impact of Dagmar Homerová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagmar Homerová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagmar Homerová more than expected).
Fields of papers citing papers by Dagmar Homerová
This network shows the impact of papers produced by Dagmar Homerová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagmar Homerová. The network helps show where Dagmar Homerová may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dagmar Homerová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2021 | 6 | |
| 3 | 2020 | 7 | |
| 4 | 2019 | 19 | |
| 5 | Increased heterologous production of the antitumoral polyketide mithramycin a by engineered Streptomyces lividans TK24 strains (vol 102, pg 857, 2018) | 2018 | 4 |
| 6 | 2012 | 1 | |
| 7 | 2012 | 18 | |
| 8 | 2009 | 1 | |
| 9 | 2004 | 4 | |
| 10 | 2003 | 102 | |
| 11 | 2002 | 43 | |
| 12 | 2002 | 16 | |
| 13 | 2001 | 3 | |
| 14 | 2001 | 12 | |
| 15 | 2001 | 0 | |
| 16 | 1999 | 23 | |
| 17 | 1999 | 1 | |
| 18 | 1996 | 14 | |
| 19 | 1995 | 9 | |
| 20 | 1993 | 12 |
About Dagmar Homerová
Dagmar Homerová is a scholar working on Endocrinology, Pharmacology and Microbiology, having authored 66 papers that have together received 1.3k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (29 papers), Bacterial Genetics and Biotechnology (24 papers), Plant-Microbe Interactions and Immunity (14 papers), Genomics and Phylogenetic Studies (14 papers), Salmonella and Campylobacter epidemiology (11 papers), RNA and protein synthesis mechanisms (8 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Bacterial biofilms and quorum sensing (7 papers). The work is most often cited by research in Endocrinology (169 citations), Pharmacology (342 citations) and Infectious Diseases (349 citations). Dagmar Homerová has collaborated with scholars based in Slovakia, United Kingdom and Germany. Frequent co-authors include Ján Kormanec, Bronislava Řežuchová, Mark Roberts, Renáta Nováková, Beatrica Ševčı́ková, Markus Bischoff, Lubomira Feckova, Gary Rowley, Brigitte Berger‐Bächi and Christiane Wolz. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.